Problem: You are on your hospital IPPE and the preceptor asks you what are some of the clinical peals and patient counseling points for fenofibrate. You say
A. use with caution and monitor closely for rhabdomyolysis if coadministered with HMG Co-A Reductase Inhibitors
B. fenofibrate products are not interchangeable
C. avoid activities requiring mental alerness or coordination until drug effects are known
D. do not use if you have severe kidney disease or liver disease